皮肤型红斑狼疮诊疗指南(2019版)

2019-03-30 中华医学会皮肤性病学分会 中华皮肤科杂志.2019,52(3):149-155.

红斑狼疮是一病谱性疾病,一端为皮肤型红斑狼疮,病变主要限于皮肤;另一端为系统性红斑狼疮,除皮肤损害以外,病变可累及多脏器和多系统。正确认识不同类型红斑狼疮的皮肤损害,有助于早期诊断、正确治疗及改善预后。为了对皮肤型红斑狼疮的诊疗提供更为科学、权威的参考依据,中华医学会皮肤性病学分会红斑狼疮研究中心在《皮肤型红斑狼疮诊疗指南(2012))基础上。结合国内外研究进展及专家建议,制订本指南。该指南修订内

中文标题:

皮肤型红斑狼疮诊疗指南(2019版)

发布日期:

2019-03-30

简要介绍:

红斑狼疮是一病谱性疾病,一端为皮肤型红斑狼疮,病变主要限于皮肤;另一端为系统性红斑狼疮,除皮肤损害以外,病变可累及多脏器和多系统。正确认识不同类型红斑狼疮的皮肤损害,有助于早期诊断、正确治疗及改善预后。为了对皮肤型红斑狼疮的诊疗提供更为科学、权威的参考依据,中华医学会皮肤性病学分会红斑狼疮研究中心在《皮肤型红斑狼疮诊疗指南(2012))基础上。结合国内外研究进展及专家建议,制订本指南。该指南修订内容主要涉及以下方面:调整皮肤型红斑狼疮的分类模式,补充Blaschko线状红斑狼疮这一特殊类型;补充完善不同类型皮肤型红斑狼疮的临床及病理特点;更新和细致说明治疗建议。本指南适用于成人及儿童皮肤型红斑狼疮。 

拓展指南:红斑狼疮相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=956840, encodeId=99dc956840e0, content=mark一下啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e15452688, createdName=ms4000000701362465, createdTime=Wed Apr 14 10:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917359, encodeId=f93b91e359a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:24:02 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901886, encodeId=c0de9018860f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Tue Nov 24 19:57:39 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880883, encodeId=31e48808837e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5d5414491, createdName=ms1000001095825748, createdTime=Sun Aug 30 14:23:25 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808583, encodeId=1f5c808583f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:10:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2021-04-14 ms4000000701362465

    mark一下啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=956840, encodeId=99dc956840e0, content=mark一下啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e15452688, createdName=ms4000000701362465, createdTime=Wed Apr 14 10:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917359, encodeId=f93b91e359a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:24:02 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901886, encodeId=c0de9018860f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Tue Nov 24 19:57:39 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880883, encodeId=31e48808837e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5d5414491, createdName=ms1000001095825748, createdTime=Sun Aug 30 14:23:25 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808583, encodeId=1f5c808583f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:10:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2021-01-17 黄伟医生

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=956840, encodeId=99dc956840e0, content=mark一下啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e15452688, createdName=ms4000000701362465, createdTime=Wed Apr 14 10:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917359, encodeId=f93b91e359a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:24:02 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901886, encodeId=c0de9018860f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Tue Nov 24 19:57:39 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880883, encodeId=31e48808837e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5d5414491, createdName=ms1000001095825748, createdTime=Sun Aug 30 14:23:25 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808583, encodeId=1f5c808583f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:10:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-11-24 1e1366a1m07(暂无匿称)

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=956840, encodeId=99dc956840e0, content=mark一下啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e15452688, createdName=ms4000000701362465, createdTime=Wed Apr 14 10:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917359, encodeId=f93b91e359a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:24:02 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901886, encodeId=c0de9018860f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Tue Nov 24 19:57:39 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880883, encodeId=31e48808837e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5d5414491, createdName=ms1000001095825748, createdTime=Sun Aug 30 14:23:25 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808583, encodeId=1f5c808583f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:10:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-30 ms1000001095825748

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=956840, encodeId=99dc956840e0, content=mark一下啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e15452688, createdName=ms4000000701362465, createdTime=Wed Apr 14 10:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917359, encodeId=f93b91e359a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:24:02 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901886, encodeId=c0de9018860f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Tue Nov 24 19:57:39 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880883, encodeId=31e48808837e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5d5414491, createdName=ms1000001095825748, createdTime=Sun Aug 30 14:23:25 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808583, encodeId=1f5c808583f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:10:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 Faye Hu

    学习了

    0